Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 6065-6075
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6065
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6065
Table 2 Characteristics of the baseline biliary stenting and stent-related event
| Variables | All patients (n = 96) | SRE group (n = 41; 43%) | no-SRE group (n = 55; 57%) | P-value for distribution within baseline parameter (χ2 test), SRE vs no-SRE groups | |
| Stents at baseline | 1 | 70 (73) | 24 (59) | 46 (84) | 0.008 |
| 2 | 21 (22) | 13 (32) | 8 (14) | ||
| 3 | 3 (3) | 3 (7) | 0 (0) | ||
| 4 | 1 (1) | 1 (2) | 0 (0) | ||
| Not specified | 1 (1) | 0 (0) | 1 (2) | ||
| Number of stents/biliary interventions at baseline | 1 previous stent/intervention | 70 (73) | 24 (59) | 46 (84) | 0.004 |
| ≥ 2 previous stent/intervention | 25 (26) | 17 (41) | 8 (15) | ||
| Not specified | 1 (1) | 0 (0) | 1 (1) | ||
| Type of stent (baseline) | Metal | 85 (89) | 37 (90) | 48 (87) | 0.170 |
| Plastic | 7 (7) | 4 (10) | 3 (5) | ||
| Not specified | 4 (4) | 0 (0) | 4 (7) | ||
| Type of SRE (SRE group only) | Cholangitis | 16 (17) | 16 (39) | - | - |
| Stent obstruction | 12 (13) | 12 (29) | - | ||
| Both | 13 (14) | 13 (32) | - | ||
| Consequence of SRE (SRE group only) | None | 15 (16) | 15 (37) | - | - |
| Chemotherapy delayed | 10 (10) | 10 (24) | - | ||
| Chemotherapy stopped | 7 (7) | 7 (17) | - | ||
| Death | 9 (9) | 9 (22) | - | ||
| Further SRE (SRE group only) | No | 27 (28) | 27 (66) | - | - |
| Yes | 14 (15) | 14 (34) | - | ||
- Citation: Lamarca A, Rigby C, McNamara MG, Hubner RA, Valle JW. Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy. World J Gastroenterol 2016; 22(26): 6065-6075
- URL: https://www.wjgnet.com/1007-9327/full/v22/i26/6065.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i26.6065